 PLANO, Texas, May 03, 2021 GLOBE NEWSWIRE -- Reata Pharmaceuticals, Inc. Nasdaq: RETA Reata, the Company, or we, a clinical-stage biopharmaceutical company, today announced that management will present and hold 1x1 meetings at the following investor conferences: 